PDCO
40
10
AIZ
80
2
CA
29
7
EXPE
91
-2
DE
46
4
HPE
59
15
NRG
47
3
GOOGL
53
5
SWK
55
5
O
19
2
TMO
36
-6
WFC
77
-2
NWS
64
-2
FOXA
46
-6
DVN
16
2
DTE
45
2
FRT
39
-2
JCI
54
-5
BDX
52
-2
VNO
54
8
PDCO
40
10
AIZ
80
2
CA
29
7
EXPE
91
-2
DE
46
4
HPE
59
15
NRG
47
3
GOOGL
53
5
SWK
55
5
O
19
2
TMO
36
-6
WFC
77
-2
NWS
64
-2
FOXA
46
-6
DVN
16
2
DTE
45
2
FRT
39
-2
JCI
54
-5
BDX
52
-2
VNO
54
8
Financhill
Back

EyePoint Pharmaceuticals Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
53

EYPT
EyePoint Pharmaceuticals

Last Price:
9.20
Seasonality Move:
27.28%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

EyePoint Pharmaceuticals Price Quote

$9.20
+0.62 (+7.23%)
(Updated: November 19, 2024 at 5:40 PM ET)

EyePoint Pharmaceuticals Key Stats

Buy
53
EyePoint Pharmaceuticals (EYPT) is a Buy
Day range:
$8.56 - $9.31
52-week range:
$5.86 - $30.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.51
P/B ratio:
2.68%
Volume:
1.3M
Avg. volume:
974.4K
1-year change:
29.02%
Market cap:
$585.6M
Revenue:
$46M
EPS:
$-1.99

How Much Does EyePoint Pharmaceuticals Make?

Is EyePoint Pharmaceuticals Growing As A Company?

EyePoint Pharmaceuticals Stock Price Performance

What Is EyePoint Pharmaceuticals 52-Week High & Low?

EyePoint Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy EyePoint Pharmaceuticals?

Is EyePoint Pharmaceuticals Cash Flow Positive?

  • What Is EYPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$113.5M
  • What Is EyePoint Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $230.8M
  • What Is EyePoint Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$170.5M

EyePoint Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    EYPT return on invested capital is -50.67%
  • What Is EyePoint Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -35.24%
  • What Is EYPT Return On Equity?
    ROE is a measure of profitability and is -50.67%

EyePoint Pharmaceuticals Earnings Date & Stock Price

EyePoint Pharmaceuticals Competitors

EyePoint Pharmaceuticals Dividend Yield

EyePoint Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -0.17%
Revenue: -30.77% 1.6%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.45
Upside from Last Price: 289.91%

Major Shareholders

  • How many EYPT shares are owned by institutional investors?
    100.7M EYPT shares are owned by institutional investors
  • How many EYPT shares are owned by insiders?
    1.4M EYPT shares are owned by insiders